This page was added on 04 June 2018.
This page was updated on [date-counter-updated-date]. View history of updates
Registered for use in people aged ≥16 years.
Combination hepatitis A and typhoid vaccine
Supplied in a dual-chamber syringe that enables the 2 vaccines to be mixed just before administration.
Each 1.0 mL dose of mixed vaccine contains:
- 160 antigen units of inactivated hepatitis A virus (GBM strain)
- 25 µg purified Vi capsular polysaccharide of Salmonella typhi strain Ty2
- 0.3 mg aluminium as aluminium hydroxide
- 2.5 µL phenoxyethanol
- 12.5 µg formaldehyde
- ≤5 µg neomycin
- <10 ng bovine serum albumin
- traces of polysorbate 80
For Product Information and Consumer Medicine Information about Vivaxim visit the Therapeutic Goods Administration website.
Additional vaccine information
For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.